Herein, we present our findings that CBX attenuated CYP‐induced cystitis in vivo and reduced acrolein‐elicited cell injury in vitro, possibly through mechanisms involving inhibition of TRPV4 channels and the channel‐mediated oxidative urothelial injury. The gene discussed is CBX1; the disease is cystitis.